Cargando…
Recent advances in treating oesophageal cancer
Esophageal cancer (EC) is an aggressive malignancy with an increasing incidence and a poor prognosis. EC is histologically divided into two major categories: adenocarcinoma (EAC) and squamous cell carcinoma (ESCC). EAC and ESCC are molecularly different and therefore treatments should reflect the re...
Autores principales: | Harada, Kazuto, Rogers, Jane E., Iwatsuki, Masaaki, Yamashita, Kohei, Baba, Hideo, Ajani, Jaffer A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531047/ https://www.ncbi.nlm.nih.gov/pubmed/33042518 http://dx.doi.org/10.12688/f1000research.22926.1 |
Ejemplares similares
-
Programmed death ligand‐1 expression in gastrointestinal cancer: Clinical significance and future challenges
por: Yamashita, Kohei, et al.
Publicado: (2020) -
Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017) -
Recent advances in the management of gastric adenocarcinoma patients
por: Harada, Kazuto, et al.
Publicado: (2018) -
Recent trend in gastric cancer treatment in the USA
por: Harada, Kazuto, et al.
Publicado: (2018) -
Neoadjuvant and adjuvant therapy for gastrointestinal stromal tumors
por: Iwatsuki, Masaaki, et al.
Publicado: (2018)